Skip to main content

Table 4 Summary of adverse events observed during the advantus™ soft chewable tablets field study

From: Development of advantus™(imidacloprid) soft chewable tablets for the treatment of Ctenocephalides felis infestations on dogs

Adverse event No. of cases in the IVP1 treated group No. of cases in the CVP2 treated group
(n (%) as total of 206 dogs) (n (%) as total of 125 dogs)
Vomiting, upset stomach 8 (3.8 %) 4 (3.2 %)
Inappetence 6 (2.9 %) 3 (2.4 %)
Lethargy 4 (1.9 %) 4 (3.2 %)
Diarrhea, flatulence 3 (1.5 %) 4 (3.2 %)
Ataxia 1 (0.5 %) None
  1. 1IVP is the advantus™ chewable tablets as the investigational veterinary product
  2. 2`CVP is the placebo soft chewable tablets as control veterinary product